ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)
Clinical trial NCT05894538 · COMPLETED
Trial details
- NCT number
- NCT05894538
- Sponsor
- Susanna Naggie, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2022-08-29
- Enrollment
- 1459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.